Novo Nordisk Operating Expenses 2012-2026 | NVO

Novo Nordisk operating expenses for the twelve months ending March 31, 2026 were $27.747B, a 14.82% increase year-over-year.

  • Novo Nordisk annual operating expenses for 2025 were $27.465B, a 16.88% increase from 2024.
  • Novo Nordisk annual operating expenses for 2024 were $23.499B, a 24.79% increase from 2023.
  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.

Novo Nordisk Operating Expenses 2012-2026 | NVO

  • Novo Nordisk annual operating expenses for 2025 were $27.465B, a 16.88% increase from 2024.
  • Novo Nordisk annual operating expenses for 2024 were $23.499B, a 24.79% increase from 2023.
  • Novo Nordisk annual operating expenses for 2023 were $18.831B, a 30.19% increase from 2022.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B